Applications of Fmoc-(S)-3-Amino-4-(3-Benzothienyl)-Butyric Acid in Industrial Manufacturing

Fmoc-(S)-3-Amino-4-(3-Benzothienyl)-Butyric Acid is widely adopted across several advanced manufacturing sectors. Its structural profile supports peptide synthesis, pharmaceutical R&D, and peptide-based API production. Our facility supplies this compound in GMP-controlled batches, enabling compliance with major pharmacopeial and pharmaceutical guidelines. Below we present detailed applications in real-world industrial processes.

1. Peptide Drug Substance Manufacturing

Pharmaceutical companies use this compound for solid-phase peptide synthesis (SPPS) in research and commercial-scale GMP operations. The Fmoc protecting group facilitates selective deprotection during assembly of complex peptide sequences, especially where conformational rigidity and aromatic substitution from the benzothienyl moiety is desired. Developers apply it for synthesizing clinical and preclinical peptide APIs where precise stereochemistry and purity are critical.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) for peptide synthesis raw materials
• United States Pharmacopeia (USP) standards for peptide APIs
• FDA 21 CFR Part 210/211 requirements for pharma manufacturing

Typical usage ratio

• Employed between 0.5–2.5 mmol per resin loading, adjusted based on peptide chain length and final dosage form
• Ratios governed by target peptide sequence and coupling yield optimization

Downstream process integration

• Integrated during initial chain elongation phase
• Undergoes cycles of coupling and Fmoc deprotection in automated synthesizers
• Contributes to N-terminal residue in synthetic scheme

Final product types

• Pharmaceutical peptide APIs for oncology, endocrine, and metabolic indications
• Clinical trial material for investigational peptide drugs
• Commercial non-biological complex drugs (NBCDs) based on peptide motifs

2. Custom Peptide Synthesis Services

Contract development and manufacturing organizations (CDMOs) and CROs apply this amino acid derivative in custom synthesis programs. The benzothienyl group imparts functional diversity to peptide libraries targeting binding, structure–activity relationship studies, and lead peptide identification for pharmaceutical partners. Strict lot traceability and batch documentation are maintained throughout the process, with emphasis on contaminant control and protected group integrity.

Industry compliance standards

• ISO 9001:2015 Quality Management for custom peptide manufacturing
• GLP (Good Laboratory Practices) for research peptides
• Synthetic peptide cGMP guidelines for clinical-grade projects
• DMF (Drug Master File) data submission best practices

Typical usage ratio

• Loaded at 0.7–1.8 mmol per resin gram in parallel synthesis
• Higher ratios for complex side-chain modifications; adjusted for solubility and sequence constraints

Downstream process integration

• Introduced at N-terminal or site-specific points in library sequences
• Followed by automated or manual purification processes (HPLC, lyophilization)
• Material tracking via batch-specific QR code through LIMS

Final product types

• Screening peptide libraries for drug discovery
• Research-only peptides for in vitro/in vivo models
• Building blocks for proprietary customers’ bioactive peptides

3. Peptide-based Bioconjugates Manufacturing

Industrial production of peptide-based bioconjugates, such as peptide–drug conjugates (PDCs), employs this intermediate for precise chemical ligation processes. The butyric acid side chain and aromatic group facilitate both covalent attachment and increase molecular rigidity, aiding conjugate stability during sterile filtration and final fill-finish operations. Manufacturers conduct full analytical QC on batches where the amino acid introduces novel scaffold sites for downstream linker chemistry.

Industry compliance standards

• GMP for APIs and intermediates intended for parenteral use (EU Annex 1)
• ICH Q6B Specifications for Biotechnological/Biological Products
• FDA Guidance for Industry: Immunogenicity Testing of Therapeutic Protein Products

Typical usage ratio

• 0.3–1.0 molar equivalents per conjugation run; modified based on drug payload size and linker length
• Adjusted upward for site-specific labeling or multi-valent conjugate programs

Downstream process integration

• Employed in late-stage peptide assembly on solid support
• Activated before bioconjugation to linkers/payloads via amide or click chemistry
• Integrated as branching point for orthogonal conjugation strategies

Final product types

• PDCs targeting cancer, autoimmune, or metabolic diseases
• Peptide–fluorophore or peptide–nanoparticle conjugates for diagnostic imaging
• Clinical lot materials for biopharmaceutical studies

4. Research Chemical Supply for Academic and Industrial R&D

University laboratories and corporate innovation centers acquire this raw material for designing novel amino acid analogs, structure-activity probes, and modified backbone peptides within medicinal chemistry research. Researchers use it to generate unique scaffolds for SAR studies and prototype molecules for IP filings. We support R&D-grade supply with full characterization reports and CoA documentation aligned with contemporary research standards.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006 for chemical registration/import in Europe
• OECD Guidelines for the Testing of Chemicals—Research Use Only status
• ISO/IEC 17025:2017 for analytical lab grade confirmation

Typical usage ratio

• 0.1–1.0 mmol per synthetic reaction, depending on molecular design and expected product scale-up
• Range tailored by project protocol, solubility, and reactivity profile

Downstream process integration

• Applied directly in manual and automated solution-phase or SPPS procedures
• Used for residue scanning and non-natural amino acid insertion
• Tracked via project-specific documentation and LIMS entries

Final product types

• Research peptides with functionalized aromatic side chains
• Prototype molecules for patent filing and licensing
• Building blocks for combinatorial chemistry